Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This is an important statement, IMHO.

You said:

Aren't you concerned that there could be dilution with an M&A, which is why Swartz had that, because it would dilute his investment.

After may 31st, who is there for them to worry about. ???

I don't know, maybe paranoid, but getting negative vibs on what we are going through with this management.

Is Swartz now our enemy or our friend? Hard to tell sometimes isn't it...



Share
New Message
Please login to post a reply